Cargando…

Elevated Asymmetric Dimethylarginine in Young Adult Survivors of Childhood Acute Lymphoblastic Leukemia: A Preliminary Report

Background: Adult survivors of childhood malignancy are predisposed to late cardiovascular (CV) complications. Our aim was to estimate plasma levels of the endogenous nitric oxide formation inhibitor asymmetric dimethylarginine (ADMA), in long-term survivors of childhood acute lymphoblastic leukemia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sulicka, Joanna, Surdacki, Andrzej, Strach, Magdalena, Kwater, Aleksander, Gryglewska, Barbara, Ćwiklińska, Magdalena, Balwierz, Walentyna, Grodzicki, Tomasz K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2012
Materias:	Other
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3810683/ https://www.ncbi.nlm.nih.gov/pubmed/22846209 http://dx.doi.org/10.3233/DMA-2012-0906

Ejemplares similares

Cranial Irradiation in Childhood Acute Lymphoblastic Leukemia Is Related to Subclinical Left Ventricular Dysfunction and Reduced Large Artery Compliance in Cancer Survivors
por: Sulicka-Grodzicka, Joanna, et al.
Publicado: (2019)

Low‐grade chronic inflammation and immune alterations in childhood and adolescent cancer survivors: A contribution to accelerated aging?
por: Sulicka‐Grodzicka, Joanna, et al.
Publicado: (2021)

Comment on: Tessari et al. Roles of Insulin, Age, and Asymmetric Dimethylarginine on Nitric Oxide Synthesis In Vivo. Diabetes 2013;62:2699–2708
por: Kruszelnicka, Olga, et al.
Publicado: (2013)

Asymmetric dimethylarginine predicts decline of glucose tolerance in men with stable coronary artery disease: a 4.5-year follow-up study
por: Surdacki, Andrzej, et al.
Publicado: (2013)

Toxic Dimethylarginines: Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA)
por: Tain, You-Lin, et al.
Publicado: (2017)

Disseminated Juvenile Xanthogranuloma and Hemophagocytic Lymphohistiocytosis Developed During Treatment of Acute Lymphoblastic Leukemia: Case Report
por: Pawińska-Wa̧sikowska, Katarzyna, et al.
Publicado: (2020)

Asymmetric Dimethylarginine and Hepatic Encephalopathy: Cause, Effect or Association?
por: Czarnecka, Anna, et al.
Publicado: (2016)

Late effects in survivors of childhood acute lymphoblastic leukemia in the context of selected gene polymorphisms
por: Kwiecinska, Kinga, et al.
Publicado: (2018)

Diabetic Retinopathy Is Associated With Elevated Serum Asymmetric and Symmetric Dimethylarginines
por: Abhary, Sotoodeh, et al.
Publicado: (2009)

Asymmetric Dimethylarginine versus Proton Pump Inhibitors Usage in Patients with Stable Coronary Artery Disease: A Cross-Sectional Study
por: Kruszelnicka, Olga, et al.
Publicado: (2016)

Differential associations of angiographic extent and severity of coronary artery disease with asymmetric dimethylarginine but not insulin resistance in non-diabetic men with stable angina: a cross-sectional study
por: Kruszelnicka, Olga, et al.
Publicado: (2013)

Meta-Analysis of Asymmetric Dimethylarginine Concentrations in Rheumatic Diseases
por: Erre, Gian Luca, et al.
Publicado: (2019)

Asymmetric Dimethylarginine in COPD Exacerbation
por: Ozkarafakili, Mufide Arzu, et al.
Publicado: (2022)

Polymorphisms of SLC19A1 80 G>A, MTHFR 677 C>T, and Tandem TS Repeats Influence Pharmacokinetics, Acute Liver Toxicity, and Vomiting in Children With Acute Lymphoblastic Leukemia Treated With High Doses of Methotrexate
por: Cwiklinska, Magdalena, et al.
Publicado: (2020)

Health status of older cancer survivors—results of the PolSenior study
por: Sulicka, Joanna, et al.
Publicado: (2018)

Asymmetric and Symmetric Dimethylarginine in Adolescents with Hyperuricemia
por: Tenderenda-Banasiuk, Edyta, et al.
Publicado: (2013)

Renal asymmetric dimethylarginine inhibits fibrosis
por: Wu, Ming, et al.
Publicado: (2020)

Asymmetric and symmetric dimethylarginines and mortality in patients with hematological malignancies—A prospective study
por: Chachaj, Angelika, et al.
Publicado: (2018)

Blood Monocyte Subsets and Selected Cardiovascular Risk Markers in Rheumatoid Arthritis of Short Duration in relation to Disease Activity
por: Klimek, Ewa, et al.
Publicado: (2014)

Differential Associations of Inflammatory and Endothelial Biomarkers with Disease Activity in Rheumatoid Arthritis of Short Duration
por: Klimek, Ewa, et al.
Publicado: (2014)

Chemerin as a Potential Marker of Resolution of Inflammation in COVID-19 Infection
por: Sulicka-Grodzicka, Joanna, et al.
Publicado: (2022)

Plasma asymmetric dimethylarginine predicts restenosis after coronary angioplasty
por: Derkacz, Arkadiusz, et al.
Publicado: (2011)

Clinical Utility of Ammonia Concentration as a Diagnostic Test in Monitoring of the Treatment with L-Asparaginase in Children with Acute Lymphoblastic Leukemia
por: Czogała, Małgorzata, et al.
Publicado: (2014)

Asymmetric Dimethylarginine, Endothelial Dysfunction and Renal Disease
por: Aldámiz-Echevarría, Luis, et al.
Publicado: (2012)

Arginine/Asymmetric Dimethylarginine Ratio in Colorectal Surgery
por: Ragina, Neli, et al.
Publicado: (2017)

Elevated Levels of Asymmetric Dimethylarginine (ADMA) in the Pericardial Fluid of Cardiac Patients Correlate with Cardiac Hypertrophy
por: Nemeth, Zoltan, et al.
Publicado: (2015)

L-arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in plasma and synovial fluid of patients with knee osteoarthritis
por: Pascale, Valerio, et al.
Publicado: (2013)

Increased symmetric dimethylarginine, but not asymmetric dimethylarginine, concentrations are associated with transient myocardial ischemia and predict outcome
por: Szabo, Zsuzsanna, et al.
Publicado: (2020)

Results of two consecutive treatment protocols in Polish children with acute lymphoblastic leukemia
por: Zawitkowska, Joanna, et al.
Publicado: (2020)

Resolution and quantification of arginine, monomethylarginine, asymmetric dimethylarginine, and symmetric dimethylarginine in plasma using HPLC with internal calibration
por: Alkaitis, Matthew S., et al.
Publicado: (2015)

Hyperuricemia induces endothelial dysfunction and accelerates atherosclerosis by disturbing the asymmetric dimethylarginine/dimethylarginine dimethylaminotransferase 2 pathway
por: Lee, Tzong-Shyuan, et al.
Publicado: (2021)

Live and let die: asymmetric dimethylarginine and septic shock
por: Böger, Rainer H
Publicado: (2006)

Mechanism of Cellular Oxidation Stress Induced by Asymmetric Dimethylarginine
por: Mohan, Srinidi, et al.
Publicado: (2012)

Asymmetric Dimethylarginine (ADMA) and Endothelial Dysfunction: Implications for Atherogenesis
por: Landim, Maurício Batista Paes, et al.
Publicado: (2009)

Asymmetric and symmetric dimethylarginines: metabolism and role in severe sepsis
por: Umbrello, M, et al.
Publicado: (2009)

The Biological Axis of Protein Arginine Methylation and Asymmetric Dimethylarginine
por: Fulton, Melody D., et al.
Publicado: (2019)

Serum Asymmetric Dimethylarginine Levels in Patients with Vasovagal Syncope
por: Atıcı, Adem, et al.
Publicado: (2019)

Cadmium-induced endothelial dysfunction mediated by asymmetric dimethylarginine
por: Al-Naemi, Hamda A., et al.
Publicado: (2020)

Metabolism of asymmetric dimethylarginine in hypoxia: from bench to bedside
por: Hannemann, Juliane, et al.
Publicado: (2020)

Long-Term Intermittent Exposure to High Altitude Elevates Asymmetric Dimethylarginine in First Exposed Young Adults
por: Lüneburg, Nicole, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_7vjgka000bjgl16b843e1fmh35